Clinical Trials Market Size Expected to Reach USD 92.45 billion, at a CAGR of 6.9% by 2030
As per the report by Fortune Business Insights, the global Clinical Trials Market size is projected to reach USD 92.45 billion in 2030, at a CAGR of 6.9% during the forecast period, 2023-2030
Pune, India, March 31, 2023 (GLOBE NEWSWIRE) — The global Clinical Trials Market size was USD 54.24 billion in 2022. The market is expected to grow from USD 57.76 billion in 2023 to USD 92.45 billion by 2030, exhibiting a CAGR of 6.9% during the forecast period. Companies have increased their focus on the development of novel treatments for chronic diseases. The market growth is fueled by the outsourcing of R&D activities. Fortune Business Insights presents this information in their report titled “Global Clinical Trials Market, 2023-2030.”
Industry Development:
October 2021: Syneos Health announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management, and artificial intelligence (AI) company.
Request a Free Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/clinical-trials-market-106930
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2023 to 2030 |
| Forecast Period 2022 to 2029 CAGR | 6.9% |
| 2030 Value Projection | USD 92.45 billion |
| Base Year | 2022 |
| Market Size in 2022 | USD 54.24 billion |
| Historical Data | 2019-2021 |
| No. of Pages | 151 |
Key Takeaways from the Clinical Trials Market:
- The rising incidence of chronic ailments is expected to boost the requirement for the creation of effective treatments.
- The growth of the market is constrained by the scarcity of qualified personnel and the exorbitant expenses of clinical trials.
- The market is categorized into several segments according to application, including renal/nephrology, cardiology, metabolic disorder, infectious disease, CNS disorder, oncology, and other fields.
- In November 2021, IQVIA unveiled its plan to aggregate data as a cornerstone for enhancing market intelligence.
- In 2022, North America produced a significant portion of the clinical trials market, generating USD 26.13 billion in revenue.
Driving factor:
Increasing Number of Clinical Trials Globally Driving the Global Market
To cater to the increasing demand to treat chronic disease, the registration of clinical trials has been growing at a rapid rate. In the U.S. study trials conducted are fewer than other countries. Most study trials are conducted outside of the U.S. and the European Union, as the process is easy and cost-effective. The stage of study and the treatments of items being developed are the major aspects of a clinical trial’s success rate.
However, experienced specialists and the adoption of advanced technologies have a limited number, which could restrict the clinical trial market growth.
Browse Complete Report Details: https://www.fortunebusinessinsights.com/clinical-trials-market-106930
Segmentation:
Phase II Segment Will Grow Rapidly Due to Growing Investment in R&D for New Therapies
Based on phase, the market is segregated into phase I, phase II, phase III, and phase IV. The phase II segment is expected to develop at the fastest CAGR. The market is expected to rise as chronic diseases are becoming more common and pharmaceutical companies are increasing investments in research & development of new therapies.
Metabolic Disorders to Grow Robustly as Chronic Diseases are becoming Common All Over the World
Based on application, the market is segmented into oncology, CNS disorder, cardiology, infectious disease, metabolic disorder, renal/nephrology, and others.
The metabolic disorder segment is anticipated to expand robustly over the forecast period. This is a result of chronic diseases such as diabetes becoming more commonplace around the world. Around 227 million individuals in Asia Pacific are estimated to have type 2 diabetes, half of which are undiagnosed and may experience long-term problems according to an OCED library article from 2020. These elements are driving the demand for CRO services in the market.
Regional insights:
Europe to Witness Stagnant Growth due to Increasing Investments in R&D
Europe held a significant clinical trials market share in 2021. Increasing investments in research and development by pharmaceutical, biotechnological, and MedTech companies will lead the region in the global market. In 2020, USD 11.30 billion was spent on research and development by Roche Diagnostics, a Swiss multinational healthcare company.
Report Coverage
The report offers:
- Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
- Comprehensive insights into the regional developments.
- List of major industry players.
- Key strategies adopted by the market players.
- Latest industry developments include product launches, partnerships, mergers, and acquisitions.
Competitive Landscape
Major Players to Maintain Dominance by Launching new Product Pipeline
The prominent players in the market who held a considerable amount of global market share in 2022 are IQVIA, Laboratory Corporation of America Holdings, and Pfizer, Inc. This is due to the company’s strong brand presence and its product pipeline. Additionally, the company focuses on developing advanced and highly effective therapeutics for the treatment of chronic diseases.
Quick Buy – https://www.fortunebusinessinsights.com/checkout-page/106930
The Report Lists the Key Companies in the Clinical Trials Market:
- IQVIA Inc. (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Parexel International Corporation (U.S.)
- Medpace Holdings, Inc. (U.S.)
- Icon plc (Ireland)
- Syneos Health (U.S.)
- WuXi AppTec (China)
- Charles River Laboratories (U.S.)
- Pfizer Inc. (U.S.)
- Lilly (U.S.)
Some major points from Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Assessment of Total Number of Clinical Trials, by Key Regions
- Key Industry Developments
- R & D expenditures, by Leading Players
- Impact of COVID-19 on Global Clinical Trials Market
- New Clinical Trials Initiatives, By Key Countries
- Overview of Private and Public Funded Clinical Trials
- Overview of Regulatory Scenario, by Key Countries
- Global Clinical Trials Market Analysis, Insights and Forecast, 2019-2030
- Market Analysis, Insights and Forecast – By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Market Analysis, Insights and Forecast – By Application
- Oncology
- CNS Disorder
- Cardiology
- Infectious Disease
- Metabolic Disorder
- Renal/Nephrology
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
- Market Analysis, Insights and Forecast – By Phase
- North America Clinical Trials Market Analysis, Insights and Forecast, 2019-2030
- Market Analysis, Insights and Forecast – By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Market Analysis, Insights and Forecast – By Application
- Oncology
- CNS Disorder
- Cardiology
- Infectious Disease
- Metabolic Disorder
- Renal/Nephrology
- Others
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
- Market Analysis, Insights and Forecast – By Phase
- Europe Clinical Trials Market Analysis, Insights and Forecast, 2019-2030
- Market Analysis, Insights and Forecast – By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Market Analysis, Insights and Forecast – By Application
- Oncology
- CNS Disorder
- Cardiology
- Infectious Disease
- Metabolic Disorder
- Renal/Nephrology
- Others
- Market Analysis, Insights and Forecast – By Country/Sub-Region
- Germany
- U.K.
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Market Analysis, Insights and Forecast – By Phase
TOC Continued…
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/clinical-trials-market-106930
FAQ:
Is clinical research a growing industry?
During the forecast period, the global Clinical Trials Market is expected to expand considerably due to the elevated occurrence of chronic ailments.
How big is the clinical trials market?
The market is predicted to demonstrate a CAGR of 6.9% during the forecast period, growing from USD 7.51 billion in 2022 to USD 92.45 billion by 2030.
Related Links:
Contract Research Organization (CRO) Services Market Size, Share, Growth Industry Report, 2020-2027
Europe CRO Services Market Share, Size, Demand and Forecast
ASEAN Contract Development And Manufacturing Organization (CDMO) Market Size, Share, Growth Industry Report
Preclinical CRO Market Share, Size, Demand and Forecast 2022-2029
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
